Archiwum hase³
glioblastoma multiforme {GBM} | periodontal treatment | Strumal carcinoid | oral cavity | Periodontitis | small cell type | Giant cell type | Clear cell tumor | Epithelial tumor | Epithelioma, | Large cell carcinoma | Neuroendocrine carcinoma | Polymyalgia rheumatica {PMR} | shoulder girdle | pelvic girdle | chondrocalcinosis | Microalbuminuria | Urinary albumin excretion {UAE} | Visceral obesity | Obstructive sleep apnea {OSA} | Diffuse idiopathic skeletal hyperostosis {DISH} | Ossification of the posterior longitudinal ligemant {OPLL} | carcinoma in situ {CIS} | Insulin receptor substrate 1 {IRS-1} | Large for gestational age {LGA} | Platelet-derived grow factor {PDGF} | Vascular cell adhesion molecule 1 {VCAM-1} | Inter-cellular adhesion molecule 1 {ICAM-1} | Transforming growth factor beta {TGFb} | intrauterine fetal growth | intraperitoneal visceral adipose tissue {VAT} | Subcutaneous adipose tissue {SAT} | Hemolysis, elevated liver enzymes and low-platelet count {HELLP } | Ambulatory Blood Pressure Monitoring {ABPM} | Primary hypertension | visceral obesity | Waist-Hip Ratio {WHR} | reactive oxygen species | spontaneously hypertensive stroke-prone rats {SHRSP} | Oxidised low-density lipoprotein {oxLDL} | Recombinant human erythropoietin {rhEPO} | Erythropoietin stimulating agents {ESA} | Nephrogenic systemic fibrosis | Gadolinium-based contrast media | renal failure | Posterior reversible encephalopathy syndrome {PRES} | Diabetes inspidus | Chronic Kidney Disease {CKD} | hyperprolactinemia | Nephrogenic systemic fibrosis {NSF} | oxidative stress | renal anemia | Contrast-induced nephropathy {CIN} | Thyrometabolic disorders | Sarcoendoplasmatic reticulum Ca2+ ATP-ase {SERCA2} | Renin–angiotensin–aldosterone system {RAA} | Rate-related heart failure | Subclinical hypothyroidism {sHT} | estimated glomerular filtration rate {eGFR} | glomerular filtration rate {GFR} | Congenital coronary artery fistule | cor triatriatum dexter, | Common atrioventricular canal {CAVC} | right ventricular outflow tract obstruction {RVOTO} | L-transposition of great arteries {L-TGA} | Bland-White-Garland syndrome | Anomalous left coronary artery arising from the pulmonary artery {ALCAPA} | Mitral valve insufficiency {MVI} | Persisteus ductus arteriosus {PDA} | severe hypokinesis | Coronary steal phenomena | Fracture risk assessment. | Dysembryoplastic neuroepithelial tumor {DNET}, {DNT} | fetus in fetu {FIF} | Pemphigus foliaceus | Favus of the scalp | Atopic dermatitis | over-diagnosis, | Hyper-IgE syndrome {HIES} | Occupational skin disease | occupational dermatoses | tinea pedis {TP} | black heel | Piezogenic papules | acantholysis | bone mineral density {BMD} | differential diagnosis | staphylococcal scalded skin syndrome {SSSS} | Neglected tropical diseases {NTD} | extracellular vesicles | Parasite-host interaction | Multivesicular body {MVB} | Pathogen-associated molecular patterns {PAMPs} | Plasmodium falciparum trafficking protein {PfPTP2} | Variable surface glycoprotein {VSG} | Helminth infection | Aetiological factor | opportunistic infestation | Multicellular parasite | Parasitic diseases | Maple syrup urine disease {MSUD} | Clear cell cancer of the ovary | Chocolate cyst (ovarian ) | Gastroesophageal reflux disease | Laryngopharyngeal reflux | Gastroesophageal reflux disease {GRD} | Transient Lower Esophageal Sphincter Relaxations {TLESRs} | Reflux symptom index {RSI} | Thyroid peroxidase antibodies {TPO-Ab} | Persistent trophoblastic disease | dyspareunia | human chorionic gonadotropin {hCG} | molar pregnancy | Mayer-Rokitansky-Küster-Hauser syndrome | Wharton vaginoplasty | Mayer-Rokitansky-Küster-Hauser syndrome {MEKH} | Congenital Absence of Uterus and Vagina {CAUV} | intestinal pseudo- -obstruction | Watermelon stomach | Protein -losing enteropathy (small intestine) | Mesenteric thrombosis | Celiac disease | aseptic peritonitis | Liver and bile duct | Hepatic artery thrombosis | Sclerosing cholangitis | malabsorption syndrome | Subglottic stenosis | Seronegative spondyloarthropathy | Fibrolamellar hepatocellular carcinoma | Aadenomatous polyposis coli {APC} | Acute Decompensated Heart Failure {ADHF} | period of vulnerability | acquired, transient condition of generalized risk | Acute coronary syndrome {ACS} | aberrant crypt foci {ACF} | peripheral vascular resistance | Gastric antral vascular ectasia {GAVE} | Mineralocorticoid receptor antagonists {MRA} | Heart failure with reduced ejection fraction {HFREF} | Cardiac resynchronization therapy {CRT} | Chain-of-care | implantable cardioverter-defibrillator {ICD} | Endometrial intraepithelial neoplasia | Endometrial intraepithelial neoplasia {EIN} | Serous tubal intraepithelial carcinoma {STIC} | Monoclonal B-cell lymphocytosis {MBL} | in situ follicular neoplasia {ISFN} | in situ mantle cell neoplasia {ISMCN} | lentigo simplex | yolk sac tumor | Struma ovarii | Peritoneal gliomatosis {PG} | Chemotherapeutic retroconversion; | Growing teratoma syndrome {GTS} | phlegmasia alba dolens {PAD} | disseminated intravascular coagulation {DIC} | ovarian teratoma | Hypercalcemia of malignancy {HM} | koilocytes | low grade squamous intraepithelial lesion {LSIL} | Postural orthostatic tachycardia syndrome {POTS} | syphilitic gumma | Protothecosis | Norwegian scabies | crusted scabies | hyperkeratotic scabies | Epithelioid trophoblastic tumor | Endocrine disruptor chemicals {EDC} | agonism | bipolar disorder | amelanotic malignant melanoma {AMM} | Hand, Foot, and Mouth Syndrome {HFMS} | small to gestational age {SGA} | Transverse cerebellum diameter {TCD} | Biparietal diameter {BPD} | Estimated fetal weight {EFW} | Cerebral-to- -placental resistance ratio {CPR} | Absent end diastolic velocity {AEDV} | Twin reversed arterial perfusion {TRAP} | Anti-gliadin antibodies {AGA} | intrauterine growth restriction {IUGR} | Dermatitis herpetiformis {DH}; Duhring disease | Non-coeliac gluten sensitivity {NCGS} | Metabolical Equivalent {MET} | acute congestive heart failure | narrow therapeutic index | angiogenic cytokine | Home arterial stiffness index {HASI} | Ambulatory blood pressure monitoring {APBM} | Ambulatory arterial stiffness index {AASI} | System arterial compliance {SAC} | Endothelium derived hiperpolarizing factor {EDHF} | Advanced glycation end-products {AGE} | Arterial stiffness | Pulse wave velocity {PWV} | Vascular smooth muscle cells {VSMC} | Augmentation index {AIx} | Pulmonary alveolar microlithiasis {PAM} | Deep infiltrating endometriosis {DIE} |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
